Bishop Opira

553 total citations
9 papers, 290 citations indexed

About

Bishop Opira is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Infectious Diseases. According to data from OpenAlex, Bishop Opira has authored 9 papers receiving a total of 290 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Public Health, Environmental and Occupational Health, 3 papers in Pediatrics, Perinatology and Child Health and 2 papers in Infectious Diseases. Recurrent topics in Bishop Opira's work include Malaria Research and Control (7 papers), Mosquito-borne diseases and control (3 papers) and Tuberculosis Research and Epidemiology (2 papers). Bishop Opira is often cited by papers focused on Malaria Research and Control (7 papers), Mosquito-borne diseases and control (3 papers) and Tuberculosis Research and Epidemiology (2 papers). Bishop Opira collaborates with scholars based in Uganda, United States and United Kingdom. Bishop Opira's co-authors include Moses R. Kamya, Grant Dorsey, Abel Kakuru, Prasanna Jagannathan, Tamara D. Clark, Diane V. Havlir, Miriam Nakalembe, John Ategeka, Patience Nayebare and Mary Muhindo and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Nature Communications.

In The Last Decade

Bishop Opira

9 papers receiving 288 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bishop Opira Uganda 6 234 102 57 38 31 9 290
Alice Ura Australia 8 272 1.2× 65 0.6× 62 1.1× 39 1.0× 38 1.2× 9 369
Richard Kajubi Uganda 13 371 1.6× 148 1.5× 79 1.4× 57 1.5× 34 1.1× 33 447
Michael Nambozi Zambia 10 302 1.3× 85 0.8× 70 1.2× 77 2.0× 14 0.5× 14 351
Rolland Bantar Tata Cameroon 10 210 0.9× 75 0.7× 73 1.3× 32 0.8× 15 0.5× 15 311
Patience Nayebare Uganda 12 397 1.7× 156 1.5× 99 1.7× 40 1.1× 73 2.4× 15 488
Hamma Maiga Mali 14 450 1.9× 114 1.1× 84 1.5× 100 2.6× 11 0.4× 24 504
Almahamoudou Mahamar United States 10 237 1.0× 80 0.8× 24 0.4× 23 0.6× 69 2.2× 27 315
John Benjamin Australia 12 258 1.1× 50 0.5× 51 0.9× 71 1.9× 8 0.3× 20 319
Carole Khairallah United Kingdom 13 458 2.0× 197 1.9× 113 2.0× 38 1.0× 59 1.9× 28 545
Sekouba Keita United States 8 171 0.7× 51 0.5× 23 0.4× 20 0.5× 48 1.5× 15 216

Countries citing papers authored by Bishop Opira

Since Specialization
Citations

This map shows the geographic impact of Bishop Opira's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bishop Opira with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bishop Opira more than expected).

Fields of papers citing papers by Bishop Opira

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bishop Opira. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bishop Opira. The network helps show where Bishop Opira may publish in the future.

Co-authorship network of co-authors of Bishop Opira

This figure shows the co-authorship network connecting the top 25 collaborators of Bishop Opira. A scholar is included among the top collaborators of Bishop Opira based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bishop Opira. Bishop Opira is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
2.
Mwebaza, Norah, Michelle E. Roh, Yi Geng, et al.. (2024). Drug–Drug Interaction Between Dihydroartemisinin–Piperaquine and Sulfadoxine‐Pyrimethamine During Malaria Chemoprevention in Pregnant Women. Clinical Pharmacology & Therapeutics. 117(2). 506–514. 2 indexed citations
3.
Chaisson, Lelia H., Fred C. Semitala, Carina Marquez, et al.. (2023). Viral suppression among adults with HIV receiving routine dolutegravir-based antiretroviral therapy and 3 months weekly isoniazid-rifapentine. AIDS. 37(7). 1097–1101. 2 indexed citations
4.
Semitala, Fred C., Lelia H. Chaisson, David W. Dowdy, et al.. (2022). Tuberculosis screening improves preventive therapy uptake (TB SCRIPT) trial among people living with HIV in Uganda: a study protocol of an individual randomized controlled trial. Trials. 23(1). 399–399. 5 indexed citations
5.
Wallender, Erika, Ali M. Ali, Emma Hughes, et al.. (2021). Identifying an optimal dihydroartemisinin-piperaquine dosing regimen for malaria prevention in young Ugandan children. Nature Communications. 12(1). 6714–6714. 11 indexed citations
6.
Muhindo, Mary, Prasanna Jagannathan, Abel Kakuru, et al.. (2019). Intermittent preventive treatment with dihydroartemisinin–piperaquine and risk of malaria following cessation in young Ugandan children: a double-blind, randomised, controlled trial. The Lancet Infectious Diseases. 19(9). 962–972. 10 indexed citations
7.
8.
Savic, Rada, Prasanna Jagannathan, Richard Kajubi, et al.. (2018). Intermittent Preventive Treatment for Malaria in Pregnancy: Optimization of Target Concentrations of Dihydroartemisinin-Piperaquine. Clinical Infectious Diseases. 67(7). 1079–1088. 22 indexed citations
9.
Kakuru, Abel, Prasanna Jagannathan, Mary Muhindo, et al.. (2016). Dihydroartemisinin–Piperaquine for the Prevention of Malaria in Pregnancy. New England Journal of Medicine. 374(10). 928–939. 155 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026